Similarly, activation of Src, a non-receptor tyrosine kinase, has been observed in many cancers including that of pancreas, and an inhibition of the Src signaling axis has been associated with inhibition of stemness and oncogenic potential [25]. This evidence concerns the gene SRC and cancer.